These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21239756)

  • 1. Assessment of subclinical vascular disease associated with ankylosing spondylitis.
    Bodnár N; Kerekes G; Seres I; Paragh G; Kappelmayer J; Némethné ZG; Szegedi G; Shoenfeld Y; Sipka S; Soltész P; Szekanecz Z; Szántó S
    J Rheumatol; 2011 Apr; 38(4):723-9. PubMed ID: 21239756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity.
    Kerekes G; Szekanecz Z; Dér H; Sándor Z; Lakos G; Muszbek L; Csipö I; Sipka S; Seres I; Paragh G; Kappelmayer J; Szomják E; Veres K; Szegedi G; Shoenfeld Y; Soltész P
    J Rheumatol; 2008 Mar; 35(3):398-406. PubMed ID: 18203326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.
    Mathieu S; Joly H; Baron G; Tournadre A; Dubost JJ; Ristori JM; Lusson JR; Soubrier M
    Rheumatology (Oxford); 2008 Aug; 47(8):1203-7. PubMed ID: 18524805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases.
    Soltész P; Dér H; Kerekes G; Szodoray P; Szücs G; Dankó K; Shoenfeld Y; Szegedi G; Szekanecz Z
    Clin Rheumatol; 2009 Jun; 28(6):655-62. PubMed ID: 19224126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis.
    Peters MJ; van Eijk IC; Smulders YM; Serne E; Dijkmans BA; van der Horst-Bruinsma IE; Nurmohamed MT
    J Rheumatol; 2010 Jan; 37(1):161-6. PubMed ID: 19955053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired endothelial function in patients with ankylosing spondylitis.
    Sari I; Okan T; Akar S; Cece H; Altay C; Secil M; Birlik M; Onen F; Akkoc N
    Rheumatology (Oxford); 2006 Mar; 45(3):283-6. PubMed ID: 16204374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices.
    Perrotta FM; Scarno A; Carboni A; Bernardo V; Montepaone M; Lubrano E; Spadaro A
    Reumatismo; 2013 Jul; 65(3):105-12. PubMed ID: 23884025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
    Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of atherosclerosis in type 2 diabetic patients by endothelial dysfunction and intima-media thickness.
    Ifrim S; Vasilescu R
    Rom J Intern Med; 2004; 42(2):343-54. PubMed ID: 15529625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications.
    Szucs G; Tímár O; Szekanecz Z; Dér H; Kerekes G; Szamosi S; Shoenfeld Y; Szegedi G; Soltész P
    Rheumatology (Oxford); 2007 May; 46(5):759-62. PubMed ID: 17244666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study.
    Chatterjee Adhikari M; Guin A; Chakraborty S; Sinhamahapatra P; Ghosh A
    Semin Arthritis Rheum; 2012 Apr; 41(5):669-75. PubMed ID: 22035626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of arterial assessments in low and high vascular disease risk groups.
    Wilson AM; O'Neal D; Nelson CL; Prior DL; Best JD; Jenkins AJ
    Am J Hypertens; 2004 Apr; 17(4):285-91. PubMed ID: 15062880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
    Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
    Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis].
    Grazio S; Grubisić F; Nemcić T; Matijević V; Skala H
    Reumatizam; 2009; 56(2):63-76. PubMed ID: 20429263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.
    Serdaroğlu Beyazal M; Erdoğan T; Türkyılmaz AK; Devrimsel G; Cüre MC; Beyazal M; Sahin I
    Clin Rheumatol; 2016 Sep; 35(9):2235-41. PubMed ID: 26847856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults.
    Erdogan D; Gullu H; Caliskan M; Yildirim E; Bilgi M; Ulus T; Sezgin N; Muderrisoglu H
    Int J Clin Pract; 2005 Nov; 59(11):1276-82. PubMed ID: 16236080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.
    Végh E; Kerekes G; Pusztai A; Hamar A; Szamosi S; Váncsa A; Bodoki L; Pogácsás L; Balázs F; Hodosi K; Domján A; Szántó S; Nagy Z; Szekanecz Z; Szűcs G
    Rheumatol Int; 2020 Mar; 40(3):427-436. PubMed ID: 31848735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome is associated with increased arterial stiffness and biomarkers of subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Sabio JM; Vargas-Hitos J; Zamora-Pasadas M; Mediavilla JD; Navarrete N; Ramirez A; Hidalgo-Tenorio C; Jáimez L; Martín J; Jiménez-Alonso J;
    J Rheumatol; 2009 Oct; 36(10):2204-11. PubMed ID: 19723903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular changes in chronic renal disease patients with secondary hyperparathyroidism.
    Bortotolotto LA; Costa-Hong V; Jorgetti V; Consolim-Colombo F; Rosa K; Silva BC; Krieger EM; De Lima JJ
    J Nephrol; 2007; 20(1):66-72. PubMed ID: 17347976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.